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Transitional Meningioma in a Dog
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ABSTRACT
Background: Dogs and cats are the most common domestic animal species diagnosed with primary neoplasms of the 
central nervous system. Of these, meningioma is the brain tumor most commonly reported in dogs and is associated with 
several neurological changes, such as seizures. The ante mortem diagnosis is difficult to make because the use of comput-
erized tomography, the gold standard for the presumptive diagnosis of brain tumors, is still a limited and expensive exam 
in veterinary medicine. The aim of this study is to report the case of a grade II transitional meningioma in a female dog 
attended and necropsied at the Veterinary Hospital of the Universidade Estadual de Santa Cruz (HV-UESC).
Case: A 13-year-old female Poodle was examined at HV-UESC with a clinical history of prostration, apathy, anorexia, 
partial vision loss, and neurological abnormalities, including seizures. The dog was being treated with phenobarbital (2 mg/
kg three times a day) for seizures and doxycycline (5 mg/kg twice a day) for anaplasmosis diagnosed prior to clinical care 
at HV-UESC. On physical examination, the dog was observed to be mentally altered, with increased aggression, walking in 
large circles to the left, tremors and spasticity of the thoracic limbs. Laboratory analysis revealed a normal complete blood 
count. Biochemical analysis revealed an increase in alanine aminotransferase (296 U/mL), alkaline phosphatase (286 U/
mL) and urea (121 mg/dL) levels. Based on the clinical and laboratory abnormalities, the suspicion of cerebral degenerative 
neuropathy or neoplasia was established. The dog was examined again approximately two months after initial presentation 
and no improvement in the dog’s neurological condition was noted; in fact, the dog´s condition had deteriorated, which was 
evidenced by worsening seizures, tetraparesis and bedsores. Due to the severity of the neurological changes, euthanasia 
was performed. After authorization from the owner, the dog was referred to the HV-UESC Necropsy Department, where 
the dog was necropsied. The primary macroscopic finding was a well-defined mass measuring approximately 2.5x1.5x1.5 
cm in the frontal cortex of the left cerebral hemisphere. The lesion was firm and white with an irregular surface and was 
adhered to the dura mater. The mass compressed the adjacent brain tissue. Histopathological analysis demonstrated a non-
encapsuled, expansive, and partially delimited neoplasm characterized by sheets of meningoendothelial cells arranged 
primarily in mantles, though sometimes in lobes, in two distinct patterns: meningoendothelial and fibrous. In addition, 
a moderate amount of psammomatous bodies were observed. These microscopic characteristics led to the diagnosis of a 
grade II transitional meningioma.
Discussion: This report describes a case of meningioma in a female dog, which is the most common type of brain tumor 
diagnosed in dogs according to the literature. The affected animal was advanced in age, a factor that is associated with 
an increased risk of developing this neoplasm. The neurological alterations noted in this report were associated with the 
neoplastic process. The macroscopic finding of a cerebral neoformation was suggestive of neoplasm; this was confirmed 
by microscopic evaluation of the mass. As has been previously reported, the clinical neurological signs of most cases of 
suspected brain tumors occur late in the disease process, at which point the neoplasm is already in an advanced stage of 
development. Thus, the prognosis of the affected animal is poor, as it was in this case, which leads to euthanasia. In summary, 
this is a report of a case of intracranial transitional meningioma accompanied by progressive neurological alterations, in 
which an ante mortem diagnosis is difficult due to the limited use of computerized tomography in routine veterinary practice.
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INTRODUCTION
Meningioma is the most common primary 
brain tumor in dogs and originates from the abnormal 
proliferation of meningoendothelial cells. The primary 
sites of development are the olfactory bulb and the 
frontal lobes, although any intracranial or extracranial 
region can be affected [2,3,7].
There are variations in clinical manifestations, 
depending on the anatomical location of the tumor, 
which may be mild early in the development of the 
neoplasia. Typically, progressively worsening neuro-
logical manifestations such as alterations of consciou-
sness, seizures, and vestibular dysfunctions occur as 
the tumor grows [11,15].
Given that the clinical manifestations are not 
pathognomonic, the diagnosis of this disease requires 
the use of specialized imaging techniques such as com-
puted tomography and magnetic resonance imaging 
[6,8,9], which are not yet available in most veterinary 
centers in Brazil. Such tests might accurately diagnose 
canine intracranial meningiomas, however, they do not 
allow for evaluation of the specific neoplastic subtype 
or gradation. Therefore, histopathological evaluation is 
necessary [11], and the use of immunohistochemistry 
techniques is also sometimes required [4,10].
The aim of this study was to report the case of 
a transitional grade II meningioma in a Poodle dog, 
aged 13 years, which was attended at the UESC Vete-
rinary Hospital. It will discuss the progressive clinical 
findings of the disease and the pathological alterations 
observed in the postmortem examination.
CASE
A 13-year-old, 3.5 kg Poodle dog was referred 
to the UESC Veterinary Hospital (Figure 1) with a 
history of prostration, seizures, partial loss of vision, 
walking in circles, and aggression for approximately 
20 days. According to the owner, the dog was being 
treated with phenobarbital1 (2 mg/kg three times daily) 
to control seizures and doxycycline2 (5 mg/kg twice 
daily) for anaplasmosis diagnosed prior to presenting 
to HV-UESC. During the clinical examination, mo-
derate dehydration, sinus arrhythmia, hepatomegaly, 
tremors, spastic anterior limbs, and pacing in wide left 
circles were observed. During the exam, behavioral 
alterations were noticed, which varied from stupor to 
intense aggression independent of stimulus.
Blood samples were collected for a complete 
blood count (CBC) and biochemical tests. The hema-
tological test showed no abnormalities. Biochemical 
analysis revealed increased serum levels of alanine 
aminotransferase (296 U/mL), alkaline phosphatase 
(286 U/mL), and urea (121 mg/dL).
Based on the clinical and laboratory abnor-
malities, a diagnosis of neurological disease with a 
cerebral localization compatible with neoplasia or 
degenerative disease was established. Nephropathy 
and liver disease were also considered as concomitant 
diseases. It was recommended that doxycycline2 be 
discontinued, phenobarbital be continued, and treat-
ment with silymarin3 (50 mg/kg once daily) initiated 
in association with propolis extract4. After two mon-
ths, the dog returned for reevaluation. According to 
the owner, there had been significant progression of 
the dog’s symptoms, with worsening seizures despite 
the use of phenobarbital, as well as the development 
of tetraparesis and bedsores. Due to the severity of 
the neurological decline, euthanasia was chosen, 
which was performed by anesthetic deepening with 
propofol5.
After authorization from the owner, the dog 
was referred to the Necropsy Sector of the HV-UESC, 
where the post-mortem examination of the animal was 
performed. The primary macroscopic finding was a 
fairly well-delimited mass in the frontal lobe of the 
left cerebral hemisphere, measuring approximately 
2.5x1.5x1.5 cm, which was firm, white in color with 
an irregular surface, and which was adhered to the 
dura mater. The mass was compressing adjacent brain 
tissue (Figure 2).Figure 1. A 13-year-old female Poodle, was attended at the Veterinary Hospital of UESC, Ilhéus, Bahia.
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Samples of the mass were collected, preserved 
in 10% formalin, and sent to the HV-UESC Histopa-
thology Laboratory, where they were processed using 
the conventional paraffin inclusion technique followed 
by hematoxylin-eosin (HE) staining. Microscopic eva-
luation revealed a non-encapsulated neoplasm which 
was partially delimited and expansive, and which was 
characterized by the proliferation of meningoendothe-
lial, polygonal, and stellate cells arranged in mantles 
or lobes and presenting in two distinct patterns: me-
ningoendothelial and fibrous (Figures 3A and 3B). The 
first consisted of moderately abundant cells without 
defined limits and with eosinophilic cytoplasm, which 
was sometimes vacuolated, with round oval nuclei, 
loose chromatin, and multiple prominent nucleoli (up 
to three per nucleus). The second pattern consisted of 
spindle-shaped cells, which were arranged in bundles 
interspersed by meningoendothelial cells and which 
had cytoplasm with imprecise boundaries and elonga-
ted nuclei. In addition, a moderate number of psammo-
matous bodies were observed. These characteristics led 
to the diagnosis of a grade II transitional meningioma.
DISCUSSION
The dog in this case report had a neoformation 
of the central nervous system that was diagnosed as a 
meningioma, which, according to the literature, is the 
most commonly diagnosed primary neoplasm of the 
central nervous system [6,7], representing about 41% 
[13] to 51.5% of intracranial tumors [14].
The female dog was a 13-year-old Poodle. 
There is disagreement among studies regarding whi-
ch breeds are most affected. Some studies report that 
dogs of the Boxer [12,15] and Poodle [12] breeds are 
predisposed to the development of this type of neo-
plasia, while others report a greater predisposition in 
Golden Retrievers, miniature Schnauzers, and mixed 
breeds [14]. There is also some evidence that dogs of 
dolichocephalic breeds, i.e. breeds with long snouts, 
are more affected [5,9].
The age of the dog presented in this case is 
consistent with the literature, which describes a linear 
relationship between longevity and the incidence of 
meningiomas, with the highest incidence in animals 
aged 12-14 years [7,9,11,12,14].
The localization of the neoplasia in the frontal 
lobe of the left cerebral hemisphere accounts for the 
neurological manifestations in this dog. The frontal 
lobe is the area of the central nervous system that 
regulates behavior. Injuries at this location result in 
behavioral changes, such as excessive aggression 
which was noted in this case. The frontal and parietal 
lobes are also responsible for the control of upper motor 
neurons, or central motor control, which accounts for 
the spasticity. Patients with frontal and parietal lobe 
lesions may also display compulsive behaviors such as 
walking in broad circles, usually on the same side of 
the lesion. In this case, both the lesion and the direction 
of circle walking were the left-sided [1].
Tumors located in the cerebral cortex may also 
lead to seizures [9,12,15]. Studies show that convulsion 
is the neurological alteration most frequently associa-
ted with intracranial tumors, occurring in about 62% of 
dogs with this type of neoplasia. This manifestation is 
not necessarily associated with the malignancy of the 
neoplasia, but rather with the localization [13]. Finally, 
the visual deficit most likely occurred due to continuity 
or compressive injury in the occipital lobe [1].
In most cases, suspicion for a cerebral neopla-
sia only occurs late in the disease process when the 
neurological signs are already evident, at which point 
Figure 2. Left cerebral hemisphere of a 13-year-old female Poodle. A white 
mass is located in the cortex, measuring approximately 1.5 cm (arrows).
Figure 3. A- Transitional grade II meningioma in a dog. Note groups of fu-
siform cells, arranged in bundles, with cytoplasm with imprecise boundaries 
and elongated nuclei [HE]. B- Transitional grade II meningioma in a dog. 
Note meningoendothelial cells with no defined limits, and with eosinophilic 
and moderately abundant cytoplasm, which is sometimes vacuolated, and 
round to oval nuclei and occasional psammomatous bodies (arrows) [HE].
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the neoplasia and its sequelae are already advanced 
and the possibility of intervention is low. Furthermore, 
imaging tests such as magnetic resonance imaging 
and computed tomography, though they have good 
sensitivity for the diagnosis of meningioma [6,8,15], 
still have limited use in veterinary medicine. In the 
geographic region where this dog was treated, this type 
of examination is not performed.
The definitive treatment for meningiomas is 
surgical excision of the mass. For this, an experienced 
veterinary neurosurgeon, anesthesia, and appropriate in-
tensive care are required [9]. Furthermore, the risks and 
benefits of surgery and anesthesia should be considered. 
In the case of a possible surgical procedure, associated 
radiotherapy is recommended [11]. In this case, neither 
surgical excision nor radiotherapy were feasible.
Chemotherapy has a low efficacy for the treat-
ment of canine meningiomas and is not recommended 
[11]. Thus, only palliative treatment for convulsive sei-
zures with phenobarbital, in addition to silymarin and 
propolis extract as antioxidant and hepato-protective 
agents, were chosen. According to other studies, pallia-
tive therapy can be achieved with phenobarbital (3-5 
mg/kg twice daily) and potassium bromide (30-40 mg/
kg once daily), potentially extending life expectancy 
by two to four months [5,9].
Despite palliative care, the patient’s neurolo-
gical condition deteriorated and the convulsive crises 
became refractory to therapy, worsening the patient’s 
quality of life. At this point, euthanasia was chosen. 
As in this case, the majority of animals affected by 
meningiomas have a poor prognosis and euthanasia is 
often indicated [7].
In the postmortem evaluation, the macroscopic 
presentation of the neoplasia was consistent with cha-
racteristics described in the literature [3]. The literature 
mentions that meningiomas in dogs develop more 
commonly in the thalamus region (the diencephalon 
portion) [12], though in this case the neoplasia was 
located in the cortical region. The diagnosis was con-
firmed by microscopic evaluation of the lesion, and the 
cellular characteristics were also consistent with those 
described in the literature for transitional meningiomas 
[2,3]. The lesion was histopathologically classified as 
transitional, which is the most commonly reported 
subtype [6,7]. Although transitional meningiomas 
are graded microscopically as grade I lesions, which 
have the best prognosis, according to the literature any 
subtype can be classified as a grade II lesion when 
presenting with aggressive behavior [3]. In this case, 
there were characteristics of malignancy, such as local 
invasion, which led to a grade II classification, which 
has a more severe prognosis.
In the case reported here, a grade II intracranial 
meningioma with associated progressive neurological 
changes was confirmed based on clinical, macroscopic, 
and histopathological findings.
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